ZOGENIX INC's ticker is ZGNX and the CUSIP is 98978L204. A total of 162 filers reported holding ZOGENIX INC in Q2 2018. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $244,000 | +7.0% | 15,000 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $228,000 | -12.0% | 15,000 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $259,000 | -11.6% | 15,000 | 0.0% | 0.01% | -43.8% |
| Q1 2021 | $293,000 | -87.3% | 15,000 | -87.0% | 0.02% | -85.3% |
| Q4 2020 | $2,299,000 | +11.5% | 115,000 | 0.0% | 0.11% | -27.8% |
| Q3 2020 | $2,062,000 | -33.6% | 115,000 | 0.0% | 0.15% | -39.4% |
| Q2 2020 | $3,106,000 | -40.2% | 115,000 | -45.2% | 0.25% | -18.6% |
| Q1 2020 | $5,194,000 | +99.2% | 210,000 | +320.0% | 0.31% | +2.7% |
| Q4 2019 | $2,607,000 | +30.2% | 50,000 | 0.0% | 0.30% | +33.6% |
| Q3 2019 | $2,002,000 | -16.2% | 50,000 | 0.0% | 0.22% | +2.8% |
| Q2 2019 | $2,389,000 | -13.2% | 50,000 | 0.0% | 0.22% | -12.9% |
| Q1 2019 | $2,751,000 | +50.9% | 50,000 | 0.0% | 0.25% | +126.4% |
| Q4 2018 | $1,823,000 | -26.5% | 50,000 | 0.0% | 0.11% | -31.7% |
| Q3 2018 | $2,480,000 | +12.2% | 50,000 | 0.0% | 0.16% | +8.1% |
| Q2 2018 | $2,210,000 | – | 50,000 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 971,875 | $24,034,000 | 14.58% |
| Eversept Partners, LP | 2,013,467 | $49,793,039 | 12.38% |
| Pinz Capital Management, LP | 98,800 | $2,443,000 | 6.40% |
| RA Capital Management | 5,275,538 | $130,464,000 | 4.12% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 281,797 | $6,955,000 | 3.17% |
| Granite Point Capital Management, L.P. | 203,462 | $5,032,000 | 2.84% |
| Avoro Capital Advisors LLC | 2,800,000 | $69,244,000 | 2.34% |
| SCOPIA CAPITAL MANAGEMENT LP | 1,029,699 | $25,464,000 | 2.33% |
| Eventide Asset Management | 2,841,300 | $70,265,000 | 2.28% |
| Perceptive Advisors | 3,452,921 | $85,390,000 | 2.22% |